Japanese drug manufacturer Shionogi & Co has recently successfully produced oral treatment for Covid-19 Xocova. Accordingly, this is the pioneering line of Covid-19 treatment products in oral form, not vaccination. The Japanese Ministry of Health in Tokyo has also evaluated the e...

Guidance documents accessible from this page represent the Agency's current thinking on good clinical practice (GCP) and the conduct of clinical trials.

Chat with us!
Legal staff
+84 919 971 945
Contact me via